Lv7
4930 积分 2021-07-31 加入
Targeting Sialylation Enhances the Therapeutic Efficacy of the Nectin-4-Targeted Antibody-Drug Conjugate Enfortumab Vedotin in Bladder Cancer
2个月前
已关闭
Life extending prostate drug to be offered in England
2个月前
已关闭
Targeting Sialylation Enhances the Therapeutic Efficacy of the Nectin-4-Targeted Antibody-Drug Conjugate Enfortumab Vedotin in Bladder Cancer
2个月前
已完结
Prostate cancer
3个月前
已完结
Acute and Substantial Vision Loss After Pembrolizumab Immunotherapy for Bladder Cancer
3个月前
已关闭
A Cell-Surface MHC-I Inhibitory Axis Promotes Immune Evasion in Cancer
4个月前
已完结
Nivolumab and Cabozantinib Combination Therapy Demonstrates Sustained Efficacy in Metastatic Renal Cell Carcinoma
5个月前
已关闭
Red Papulonodules in a Kidney Transplant Recipient
5个月前
已关闭
Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer
5个月前
已关闭
Efficacy and Safety of BL-B01D1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: A Phase II Clinical Trial
5个月前
已完结
皖公网安备34019202002308
